title: Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.
abstract: CYP3A4 is a dominant human liver cytochrome P450 enzyme engaged in the metabolism and disposition of >50% of clinically relevant drugs and held responsible for many adverse drug-drug interactions. CYP3A4 and its mammalian liver CYP3A orthologs are endoplasmic reticulum (ER)-anchored monotopic proteins that undergo ubiquitin (Ub)-dependent proteasomal degradation (UPD) in an ER-associated degradation (ERAD) process. These integral ER proteins are ubiquitinated in vivo, and in vitro studies have identified the ER-integral gp78 and the cytosolic co-chaperone, CHIP (C terminus of Hsp70-interacting protein), as the relevant E3 Ub-ligases, along with their cognate E2 Ub-conjugating enzymes UBC7 and UbcH5a, respectively. Using lentiviral shRNA templates targeted against each of these Ub-ligases, we now document that both E3s are indeed physiologically involved in CYP3A ERAD/UPD in cultured rat hepatocytes. Accordingly, specific RNAi resulted in ≈80% knockdown of each hepatic Ub-ligase, with a corresponding ≈2.5-fold CYP3A stabilization. Surprisingly, however, such stabilization resulted in increased levels of functionally active CYP3A, thereby challenging the previous notion that E3 recognition and subsequent ERAD of CYP3A proteins required ab initio their structural and/or functional inactivation. Furthermore, coexpression in HepG2 cells of both CYP3A4 and gp78, but not its functionally inactive RING-finger mutant, resulted in enhanced CYP3A4 loss greater than that in corresponding cells expressing only CYP3A4. Stabilization of a functionally active CYP3A after RNAi knockdown of either of the E3s, coupled with the increased CYP3A4 loss on gp78 or CHIP coexpression, suggests that ERAD-associated E3 Ub-ligases can influence clinically relevant drug metabolism by effectively regulating the physiological CYP3A content and consequently its function.
authors.affiliation: Department of Cellular & Molecular Pharmacology, Bioengineering & Therapeutic Sciences and the Liver Center, University of California, San Francisco, California 94158-2517, USA.
authors.forename: Sung-Mi
authors.initials: SM
authors.lastname: Kim
authors.forename: Poulomi
authors.initials: P
authors.lastname: Acharya
authors.forename: Juan C
authors.initials: JC
authors.lastname: Engel
authors.forename: Maria Almira
authors.initials: MA
authors.lastname: Correia
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D051544:Cytochrome P-450 CYP3A / Q000235:genetics / Q000378:metabolism*; D004721:Endoplasmic Reticulum / Q000378:metabolism; D004795:Enzyme Stability; D057809:HEK293 Cells; D056945:Hep G2 Cells; D022781:Hepatocytes / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D006801:Humans; D015151:Immunoblotting; D008099:Liver / Q000166:cytology / Q000201:enzymology; D008297:Male; D008856:Microscopy, Fluorescence; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D034622:RNA Interference; D051381:Rats; D017207:Rats, Sprague-Dawley; D060285:Receptors, Autocrine Motility Factor; D018121:Receptors, Cytokine / Q000235:genetics / Q000378:metabolism*; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism*; D054875:Ubiquitination
chemical_list: D018121:Receptors, Cytokine; D051544:Cytochrome P-450 CYP3A; C555000:AMFR protein, human; D060285:Receptors, Autocrine Motility Factor; C540442:Stub1 protein, rat; D044767:Ubiquitin-Protein Ligases; D046988:Proteasome Endopeptidase Complex
references.citation: Biochemistry. 2001 Sep 25;40(38):11318-26
references.pmid: 11560479
references.citation: J Pharmacol Exp Ther. 2005 Jul;314(1):128-38
references.pmid: 15769864
references.citation: Biochemistry. 1998 Dec 15;37(50):17448-57
references.pmid: 9860860
references.citation: J Cell Biol. 2002 Jul 8;158(1):91-101
references.pmid: 12105183
references.citation: PLoS One. 2009;4(2):e4531
references.pmid: 19225562
references.citation: Biochemistry. 2009 Sep 8;48(35):8483-90
references.pmid: 19642705
references.citation: Expert Rev Anticancer Ther. 2008 Feb;8(2):207-17
references.pmid: 18279062
references.citation: Hum Mol Genet. 2010 May 1;19(9):1741-55
references.pmid: 20147319
references.citation: J Biol Chem. 2010 Mar 19;285(12):8830-9
references.pmid: 20089858
references.citation: Biochemistry. 2007 Jul 3;46(26):7793-803
references.pmid: 17550236
references.citation: J Biol Chem. 2003 Dec 5;278(49):49332-41
references.pmid: 14507928
references.citation: Nature. 2006 Mar 23;440(7083):551-5
references.pmid: 16554822
references.citation: J Biol Chem. 1997 Apr 11;272(15):9771-8
references.pmid: 9092510
references.citation: Mol Cell. 2005 Sep 16;19(6):829-40
references.pmid: 16168377
references.citation: Annu Rev Pharmacol Toxicol. 2005;45:439-64
references.pmid: 15822184
references.citation: Nat Cell Biol. 2001 Jan;3(1):100-5
references.pmid: 11146634
references.citation: J Biol Chem. 2004 Dec 17;279(51):52970-7
references.pmid: 15466472
references.citation: Exp Biol Med (Maywood). 2010 Mar;235(3):278-89
references.pmid: 20404045
references.citation: J Biol Chem. 2001 May 11;276(19):16193-200
references.pmid: 11278356
references.citation: Arch Biochem Biophys. 1992 Sep;297(2):228-38
references.pmid: 1497342
references.citation: Drug Metab Dispos. 1999 Aug;27(8):909-15
references.pmid: 10421618
references.citation: Nat Cell Biol. 2001 Jan;3(1):93-6
references.pmid: 11146632
references.citation: Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2836-42
references.pmid: 15665051
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11589-94
references.pmid: 16868077
references.citation: J Biol Chem. 2001 Nov 16;276(46):42938-44
references.pmid: 11557750
references.citation: Science. 2006 Oct 13;314(5797):268-74
references.pmid: 16959974
references.citation: J Biol Chem. 2007 Sep 14;282(37):26865-26873
references.pmid: 17650504
references.citation: Cell. 2006 Aug 11;126(3):571-82
references.pmid: 16901789
references.citation: Nat Cell Biol. 2001 Jan;3(1):24-9
references.pmid: 11146622
references.citation: J Biol Chem. 2006 Feb 24;281(8):4646-53
references.pmid: 16373356
references.citation: Genes Dev. 2001 Oct 15;15(20):2660-74
references.pmid: 11641273
references.citation: Mol Cell Biol. 2008 Jun;28(12):4018-25
references.pmid: 18411298
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):341-6
references.pmid: 16407162
references.citation: Nat Cell Biol. 2007 Apr;9(4):379-90
references.pmid: 17369820
references.citation: Chem Rev. 2009 Apr;109(4):1561-74
references.pmid: 19243134
references.citation: Biochem J. 2005 Jun 1;388(Pt 2):647-55
references.pmid: 15673284
references.citation: Biochemistry. 2005 Dec 13;44(49):16333-40
references.pmid: 16331994
references.citation: Nat Med. 2007 Dec;13(12):1504-9
references.pmid: 18037895
references.citation: Mol Pharmacol. 2002 May;61(5):1146-53
references.pmid: 11961133
references.citation: Semin Cell Dev Biol. 2007 Dec;18(6):780-91
references.pmid: 17942349
references.citation: J Biol Chem. 2004 Oct 29;279(44):45676-84
references.pmid: 15331598
references.citation: Nat Rev Mol Cell Biol. 2008 Dec;9(12):944-57
references.pmid: 19002207
references.citation: Drug Metab Dispos. 2004 Jul;32(7):699-706
references.pmid: 15205384
references.citation: J Biol Chem. 2009 Feb 27;284(9):5671-84
references.pmid: 19095658
references.citation: J Biol Chem. 2004 Sep 10;279(37):38184-93
references.pmid: 15247208
references.citation: Arch Biochem Biophys. 2009 Mar 1;483(1):66-74
references.pmid: 19103148
references.citation: Biochem J. 1999 Jun 1;340 ( Pt 2):453-8
references.pmid: 10333489
references.citation: Mol Pharmacol. 2006 Jun;69(6):1897-904
references.pmid: 16556771
references.citation: Cell Mol Life Sci. 2004 Jul;61(13):1546-61
references.pmid: 15224180
references.citation: Biochem Biophys Res Commun. 2009 Dec 18;390(3):758-62
references.pmid: 19835843
references.citation: Arch Biochem Biophys. 1999 Oct 15;370(2):258-70
references.pmid: 10510285
references.citation: J Biol Chem. 2004 Jan 30;279(5):3525-34
references.pmid: 14593114
references.citation: Drug Metab Rev. 2003 May-Aug;35(2-3):107-43
references.pmid: 12959413
references.citation: EMBO J. 2003 Oct 15;22(20):5446-58
references.pmid: 14532117
references.citation: Arch Biochem Biophys. 2001 Sep 1;393(1):106-16
references.pmid: 11516167
references.citation: Mol Biol Cell. 2008 Apr;19(4):1328-36
references.pmid: 18216283
references.citation: Nature. 2007 Mar 15;446(7133):333-7
references.pmid: 17310145
references.citation: Biochemistry. 1997 Dec 2;36(48):14741-50
references.pmid: 9398194
references.citation: Mol Cell Biol. 1999 Jun;19(6):4535-45
references.pmid: 10330192
references.citation: Mol Cell. 2009 Jun 26;34(6):674-85
references.pmid: 19560420
references.citation: Mol Pharmacol. 2005 May;67(5):1460-9
references.pmid: 15703377
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14422-7
references.pmid: 11724934
references.citation: Semin Cell Dev Biol. 2007 Dec;18(6):770-9
references.pmid: 17950636
references.citation: Arch Biochem Biophys. 1987 Nov 1;258(2):436-51
references.pmid: 3674884
references.citation: Cell Stress Chaperones. 2003 Winter;8(4):303-8
references.pmid: 15115282
references.citation: Expert Opin Drug Metab Toxicol. 2007 Feb;3(1):33-49
references.pmid: 17269893
references.citation: Mol Pharmacol. 2009 Sep;76(3):503-15
references.pmid: 19520899
references.citation: Toxicol Appl Pharmacol. 2004 Sep 15;199(3):316-31
references.pmid: 15364547
references.citation: J Biol Chem. 1984 Jun 10;259(11):6812-7
references.pmid: 6725272
references.citation: EMBO Rep. 2001 Dec;2(12):1133-8
references.pmid: 11743028
references.citation: Arch Biochem Biophys. 1999 May 1;365(1):45-53
references.pmid: 10222037
references.citation: Mol Pharmacol. 2010 Apr;77(4):575-92
references.pmid: 20071449
references.citation: Mol Biol Cell. 1998 Jan;9(1):209-22
references.pmid: 9437001
references.citation: Arch Biochem Biophys. 1999 May 1;365(1):31-44
references.pmid: 10222036
references.citation: Biochem Pharmacol. 1989 Apr 15;38(8):1313-9
references.pmid: 2495801
references.citation: Cell. 2008 Jan 11;132(1):101-12
references.pmid: 18191224